Medicare billing address
CMS Medicare provider billing file
10500 Montgomery RdCincinnati, OH 45242
CMS public data · NPI 1528406840
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Ahmed O Giwa, D.O
Specialty
Credential
D.O
NPI
1528406840
Primary source state
OH
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Ahmed O Giwa, D.O from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
10500 Montgomery RdCMS Doctors & Clinicians file
1362 E Stroop RdIn the 2024 CMS provider billing file, this NPI had 465 Medicare beneficiaries and 2,361 total services. The average beneficiary age was 76, and the average HCC risk score was 3.9.
Total Medicare allowed amount
$261,434.43
Total Medicare payment amount
$203,316.72
Medicare beneficiaries
465
Total services
2,361
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Chronic kidney disease
75%
CMS beneficiary-panel share
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Heart failure
68%
CMS beneficiary-panel share
Ischemic heart disease
62%
CMS beneficiary-panel share
Diabetes
58%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 1,056 | $111.35 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 318 | $161.71 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 127 | $86.16 |
| Hemodialysis procedure with physician evaluation | 111 | $67.11 |
| Dialysis procedure including 1 evaluation | 91 | $80.36 |
| Hemodialysis procedure requiring repeated evaluation | 84 | $96.51 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 58 | $333.70 |
| Dialysis procedure requiring repeat evaluation | 21 | $115.54 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1528406840. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Allopurinol | Allopurinol | 54 | 88 | $197.54 |
| 2 | Farxiga | Dapagliflozin Propanediol | 47 | 62 | $34,125.15 |
| 3 | Furosemide | Furosemide | 46 | 94.7 | $363.51 |
| 4 | Bumetanide | Bumetanide | 40 | 63.7 | $2,265.06 |
| 5 | Spironolactone | Spironolactone | 37 | 61 | $279.39 |
| 6 | Amlodipine Besylate | Amlodipine Besylate | 36 | 65 | $65.19 |
| 7 | Calcium Acetate | Calcium Acetate | 35 | 51.5 | $1,928.89 |
| 8 | Calcitriol | Calcitriol | 27 | 52 | $640.24 |
| 9 | Clonidine Hcl | Clonidine Hcl | 23 | 40 | $73.19 |
| 10 | Velphoro | Sucroferric Oxyhydroxide | 22 | 28 | $26,097.19 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2013
Group/practice field
Kidney Care Specialists, Llc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.